MET.PRA / MetLife, Inc. - Preferred Stock - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 2, 2025 METLIFE, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 2, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

MetLife Announces Full Redemption of Series G Preferred Stock Full Redemption of 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G

EX-99.1 Exhibit 99.1 MetLife Announces Full Redemption of Series G Preferred Stock Full Redemption of 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G NEW YORK, September 2, 2025 — MetLife, Inc. (NYSE: MET) today announced that it will redeem all outstanding shares of its 3.850% Fixed Rate Reset Non-Cumulative Preferred Stock, Series G, liquidation preference of $1,000 per share (“

MetLife Declares Third Quarter 2025 Preferred Stock Dividends

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Declares Third Quarter 2025 Preferred Stock Dividends NEW YORK, August 15, 2025 – MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.35263005 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquid

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 15, 2025 METLIFE, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 15, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife, I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2025 METLIFE, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 6, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Assets Under Management Exhibit 99.3 June 30, 2025 Investors turn to MetLife Investment Management for our client-centric approach and long-established expertise in Insurance Solutions, Fixed Income, Private Capital, Real Estate and Small to Mid-Cap

ex993q22025totalaum Assets Under Management Exhibit 99.3 June 30, 2025 Investors turn to MetLife Investment Management for our client-centric approach and long-established expertise in Insurance Solutions, Fixed Income, Private Capital, Real Estate and Small to Mid-Cap Value Equities. We aim to meet a range of long-term investment objectives and risk-adjusted returns over time by building sustaina

Second Quarter Financial Supplement June 30, 2025

Table of Contents Exhibit 99.2 Second Quarter Financial Supplement June 30, 2025 2 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Adjust

2Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public di

ex994q225supplementalsli 2Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

Page 1 of 23

Page 1 of 23 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Announces 2Q 2025 Results Comment from Michel Khalaf, President and Chief Executive Officer: This quarter, we continued to execute our New Frontier strategy to create value for our customers and shareholders. While the quarter didn’t demonstrate the full earnings power of MetLife, we saw clear momentum

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2025 METLIFE, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 29, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

MetLife Names Adrienne O’Neill as Chief Accounting Officer

EX-99.1 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Names Adrienne O’Neill as Chief Accounting Officer NEW YORK, July 30, 2025 — MetLife, Inc. (NYSE: MET) today announced that Adrienne O’Neill will join the company as Executive Vice President and Chief Accounting Officer, effective Sept. 2, 2025. She will report to John McCallion, Executive Vice President and

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 1, 2025 METLIFE, INC.

Chariot Re Launches with Co-Sponsorship by MetLife and General Atlantic

Exhibit 99.1 Chariot Re Launches with Co-Sponsorship by MetLife and General Atlantic NEW YORK – July 1, 2025 – MetLife, Inc., General Atlantic, and Chariot Reinsurance, Ltd. (Chariot Re), an independent Bermuda-based Class E life and annuity reinsurance company, today announced the completion of Chariot Re’s initial reinsurance transaction with a subsidiary of MetLife. Chariot Re will reinsure app

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 23, 2025 METLIFE, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 23, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2025 METLIFE, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2025 METLIFE, INC. (Exac

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 17, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Statement of Eligibility on Form T-1 of The Bank of New York Mellon Trust Company, N.A., as Trustee under the Subordinated Indenture, dated as of June 21, 2005.

EX-25.2 Exhibit 25.2 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its char

Statement of Eligibility on Form T-1 of The Bank of New York Mellon Trust Company, N.A., as Trustee under the Senior Indenture, dated as of November 9, 2001.

EX-25.1 Exhibit 25.1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ☐ CHECK IF AN APPLICATION TO DETERMINE ELIGIBILITY OF A TRUSTEE PURSUANT TO SECTION 305(b)(2) THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (Exact name of trustee as specified in its char

Filing Fee Table.

Exhibit 107 Calculation of Filing Fee Table FORM S-3 (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered and Carry Forward Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Registered Proposed  Maximum  Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of  Registration  Fee Carry

As filed with the Securities and Exchange Commission on May 16, 2025

S-3ASR Table of Contents As filed with the Securities and Exchange Commission on May 16, 2025 Registration No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2025 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number) (

MetLife Declares Second Quarter 2025 Preferred Stock Dividends

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Declares Second Quarter 2025 Preferred Stock Dividends NEW YORK, May 15, 2025 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.35141735 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidat

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife,

First Quarter Financial Supplement March 31, 2025

Table of Contents Exhibit 99.2 First Quarter Financial Supplement March 31, 2025 1 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Adjust

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

METLIFE ANNOUNCES $10 BILLION VARIABLE ANNUITY RISK TRANSFER TRANSACTION

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES $10 BILLION VARIABLE ANNUITY RISK TRANSFER TRANSACTION • Agreement with a subsidiary of Talcott Financial Group to reinsure approximately $10 billion of U.S. retail variable annuity and rider reserves • Transaction demonstrates MetLife’s focused execution across New Frontier strategic priorities NEW YORK,

1Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public di

1Q25 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 30, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Page 1 of 23

Exhibit 99.1 For Immediate Release | Global Communications | MetLife,Inc. MetLife Announces 1Q 2025 Results •Net income increased 10% to $879 million. •Premiums, fees and other revenues (PFOs) increased 14% to $13.6 billion. •Adjusted earnings rose 1% to $1.3 billion. Higher life underwriting margins, volume growth and variable investment income were partially offset by unfavorable foreign currenc

Assets Under Management March 31, 2025 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate. We aim to deliver strong, risk-adjusted retu

Assets Under Management March 31, 2025 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 27, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Pricing Agreement, dated as of March 11, 2025, among the Company and BNP Paribas Securities Corp., BofA Securities, Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and TD Securities (USA) LLC, as representatives of the several underwriters named therein.

Exhibit 1.2 PRICING AGREEMENT March 11, 2025 BNP Paribas Securities Corp. BofA Securities, Inc. Deutsche Bank Securities Inc. J.P. Morgan Securities LLC Morgan Stanley & Co. LLC TD Securities (USA) LLC As Representatives of the several Underwriters named in Schedule I hereto c/o BNP Paribas Securities Corp. 787 Seventh Avenue New York, New York 10019 c/o BofA Securities, Inc. One Bryant Park New Y

Thirteenth Supplemental Indenture, dated as of March 13, 2025, between the Company and the Trustee.

EX-4.2 Exhibit 4.2 THIRTEENTH SUPPLEMENTAL INDENTURE among METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 13, 2025 TABLE OF CONTENTS Page ARTICLE I  DEFINITIONS 2 Section 1.1. Definitions of Terms 2 ARTICLE II GENERAL TERMS AND CONDITIONS OF THE SUBORDINATED DEBENTURES 9 Section 2.1. Designation and Principal Amount 9 Section 2.2. Maturi

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 11, 2025 METLIFE, INC.

Underwriting Agreement, dated as of March 11, 2025, among the Company and BNP Paribas Securities Corp., BofA Securities, Inc., Deutsche Bank Securities Inc., J.P. Morgan Securities LLC, Morgan Stanley & Co. LLC, and TD Securities (USA) LLC, as representatives of the several underwriters named therein.

EX-1.1 Exhibit 1.1 METLIFE, INC. DEBT SECURITIES UNDERWRITING AGREEMENT March 11, 2025 To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described Ladies and Gentlemen: From time to time, MetLife, Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Ann

Termination of Replacement Capital Covenants.

Exhibit 4.7 This Termination of Replacement Capital Covenants, dated as of March 13, 2025 (this “Termination”), is made by MetLife, Inc., a Delaware corporation (together with its successors and assigns, the “Corporation”). R E C I T A L S WHEREAS, the Corporation (i) previously issued the 10.750% Fixed-to-Floating Rate Junior Subordinated Debentures due 2069 of the Corporation (the “2069 JSDs”) a

MetLife, Inc. 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055

Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 Prospectus Supplement (To Prospectus Dated November 17, 2022) MetLife, Inc. $1,000,000,000 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055 The 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055 (the “Debentures,” are MetLife, Inc.’s unsecured, subordinated debt instruments and will bear interest

Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc.

MetLife, Inc. $1,000,000,000 6.350% Fixed-to-Fixed Reset Rate Subordinated Debentures due 2055 Final Term Sheet March 11, 2025

Filed pursuant to Rule 433 March 11, 2025 Relating to Preliminary Prospectus Supplement dated March 11, 2025 to Prospectus dated November 17, 2022 Registration Statement No.

SUBJECT TO COMPLETION, DATED MARCH 11, 2025

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 The information contained in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy the Debentures in any jurisdiction where the offer or sale is not permitted

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

MetLife Confirms First Quarter 2025 Series A Preferred Stock Dividend

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Confirms First Quarter 2025 Series A Preferred Stock Dividend NEW YORK, March 5, 2025 — MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2025 dividend of $0.35516415 per share on the company’s floating rate non-cumulative preferred stock, Serie

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 4, 2025 METLIFE, INC.

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 25, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

Form of Performance Share Agreement under the 2025 SIC Plan, effective January 1, 2025.*

EXHIBIT 10.30 PERFORMANCE SHARE AGREEMENT MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Performance Shares (your “Performance Shares”). Your Performance Shares are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Performance Share Agreement (this “Agreement”), which includes

Form of Unit Option Agreement (Ratable Exercisability in Thirds) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.41 UNIT OPTION AGREEMENT (Ratable Exercisability in Thirds) [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), you [name] were granted [number] Unit Options (your “Unit Options”). Your Unit Options are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Unit Option Agreement

Form of Restricted Stock Unit Agreement (Ratable Period of Restriction Ends in Thirds) under the 2025 SIC Plan, effective January 1, 2025.*

EXHIBIT 10.32 RESTRICTED STOCK UNIT AGREEMENT (Ratable Period of Restriction Ends in Thirds) MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Restricted Stock Units. Your Restricted Stock Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Stock Unit Agreement

Amendment Number 13 to the MetLife Auxiliary Retirement Plan (as amended and restated, effective January 1, 2008), dated May 17, 2024 (effective April 1, 2024).*

Exhibit 10.17.17 AMENDMENT NUMBER 13 TO THE METLIFE AUXILIARY RETIREMENT PLAN (As amended and restated effective January 1, 2008) The MetLife Auxiliary Retirement Plan (the “Plan”) is hereby amended, effective as of April 1, 2024, as follows: Section 4.4(c) shall be amended by adding the following after the final paragraph: With respect to 409A PRA/PLS Benefits that are 409A Benefits, a Salaried P

Form of Restricted Unit Agreement (Ratable Period of Restriction Ends in Thirds) under the 2025 SIC Plan, effective January 1, 2025 (March Expiration).*

Exhibit 10.36 RESTRICTED UNIT AGREEMENT (Ratable Period of Restriction Ends in Thirds) [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), you [name] were granted [number] Restricted Units. Your Restricted Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Unit Agr

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-15787 MetLife, Inc.

Form of Restricted Unit Agreement (Three-Year “Cliff” Period of Restriction) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.37 RESTRICTED UNIT AGREEMENT (Three-Year “Cliff” Period of Restriction) [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), you [name] were granted [number] Restricted Units. Your Restricted Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Unit Agreeme

Form of Stock Option Agreement (Three-Year “Cliff” Exercisability) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.39 STOCK OPTION AGREEMENT (Three-Year “Cliff” Exercisability) MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Stock Options (your “Stock Options”). Your Stock Options are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Stock Option Agreement (this “Agreement”), whi

Subsidiaries of the Registrant.

1 Exhibit 21.1 METLIFE, INC. As of 12/31/24 Wholly-Owned Active Subsidiaries1 1.10700 WILSHIRE, LLC (DE) 2.1201 TAB MANAGER, LLC (DE) 3.1350 EYE STREET MANAGER LLC (DE) 4.1350 EYE STREET OWNER LLC (DE) 5.150 NORTH RIVERSIDE PE MEMBER, LLC (DE) 6.1960 GRAND FUND LP (DE) 7.1960 GRAND GP LLC (DE) 8.1960 GRAND MANAGER LLC (DE) 9.1960 GRAND OWNER LLC (DE) 10.1960 GRAND VENTURE LLC (DE) 11.225 6th STREE

Award Agreement Supplement under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.42 AWARD AGREEMENT SUPPLEMENT S-1. Supplement is Part of Award Agreement. This Award Agreement Supplement (this “Supplement”) provides terms that are part of your Award Agreement (the “Agreement”) under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”). In this Supplement, “Award” refers to the Performance Shares, Restricted Stock Units, Stock Options, Performanc

Form of Restricted Stock Unit Agreement (Ratable Period of Restriction Ends in Thirds) under the 2025 SIC Plan, effective January 1, 2025 (March Expiration).*

Exhibit 10.33 RESTRICTED STOCK UNIT AGREEMENT (Ratable Period of Restriction Ends in Thirds) MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Restricted Stock Units. Your Restricted Stock Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Stock Unit Agreement

Form of Restricted Stock Unit Agreement (Three-Year “Cliff” Period of Restriction) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.34 RESTRICTED STOCK UNIT AGREEMENT (Three-Year “Cliff” Period of Restriction) MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Restricted Stock Units. Your Restricted Stock Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Stock Unit Agreement (th

Form of Unit Option Agreement (Three-Year “Cliff” Exercisability) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.40 UNIT OPTION AGREEMENT (Three-Year “Cliff” Exercisability) [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), you [name] were granted [number] Unit Options (your “Unit Options”). Your Unit Options are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Unit Option Agreemen

etLife Insider Trading Polic

Exhibit 19.1 Guide to MetLife's Insider Trading Policy1 (Adopted, as amended and restated, by the MetLife, Inc. Board of Directors on December 12, 2023 and effective as of such date) Insider Trading: Basic Concepts Pledging Understanding MetLife’s Insider Trading Policy Scheduled Blackout Periods Rule 10b5-1 Plans MetLife, Inc. Insider Trading Policy Insider Trading: Basic Concepts It is the polic

Form of Stock Option Agreement (Ratable Exercisability in Thirds) under the 2025 SIC Plan, effective January 1, 2025.

Exhibit 10.38 STOCK OPTION AGREEMENT (Ratable Exercisability in Thirds) MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Stock Options (your “Stock Options”). Your Stock Options are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Stock Option Agreement (this “Agreement”), whic

Form of Restricted Unit Agreement (Ratable Period of Restriction Ends in Thirds) under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.35 RESTRICTED UNIT AGREEMENT (Ratable Period of Restriction Ends in Thirds) [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), you [name] were granted [number] Restricted Units. Your Restricted Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this Restricted Unit Agr

Form of Performance Unit Agreement under the 2025 SIC Plan, effective January 1, 2025.*

Exhibit 10.31 PERFORMANCE UNIT AGREEMENT [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Performance Units (your “Performance Units”) and approves and ratifies such grant. Your Performance Units are subject to the terms and conditions of the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”) and this

Amendment Number Fifteen to the MetLife Leadership Deferred Compensation Plan, dated May 17, 2024 (effective April 1, 2024).*

Exhibit 10.22.16 AMENDMENT NUMBER FIFTEEN TO THE METLIFE LEADERSHIP DEFERRED COMPENSATION PLAN (As amended and restated effective with respect to salary and Cash Incentive Compensation January 1, 2005 and with respect to Stock Compensation, April 15, 2005) The MetLife Leadership Deferred Compensation Plan (“the Plan”) is hereby amended, effective as of April 1, 2024, as follows: Section 4.11 shall

Award Agreement Supplement under the 2025 SIC Plan (65), effective January 1, 2025.*

Exhibit 10.43 AWARD AGREEMENT SUPPLEMENT S-1. Supplement is Part of Award Agreement. This Award Agreement Supplement (this “Supplement”) provides terms that are part of your Award Agreement (the “Agreement”) under the MetLife, Inc. 2025 Stock and Incentive Compensation Plan (the “Plan”). In this Supplement, “Award” refers to the Performance Shares, Restricted Stock Units, Stock Options, Performanc

Amendment Number 9 to the MetLife Auxiliary Match Plan (Amended and Restated Effective January 1, 2008), dated May 17, 2024 (effective April 1, 2024).*

Exhibit 10.20.10 AMENDMENT NUMBER 9 TO THE METLIFE AUXILIARY MATCH PLAN (Amended and Restated, Effective January 1, 2008) The MetLife Auxiliary Match Plan (the “Plan”) is hereby amended, effective as of April 1, 2024, as follows: Section 4.11 shall be added to the Plan with the following language: 4.11 Redeferrals: Except as provided in Section 4.4(b), a Participant may change the time and/or form

Description of Securities.

Exhibit 4.18 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of MetLife, Inc.’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is a summary and does not purport to be complete. It is qualified in its entirety by reference to our amended an

MetLife Announces First Quarter 2025 Preferred Stock Dividend Actions Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. MetLife Announces First Quarter 2025 Preferred Stock Dividend Actions Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation NEW YORK, February 18, 2025 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock di

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 18, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

Assets Under Management December 31, 2024 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate. We aim to deliver strong, risk-adjusted r

Assets Under Management December 31, 2024 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate.

Fourth Quarter Financial Supplement December 31, 2024

Table of Contents Exhibit 99.2 Fourth Quarter Financial Supplement December 31, 2024 4 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Ad

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 5, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

4Q24 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other pri

4Q24 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

MetLife Announces Full Year and Fourth Quarter 2024 Results

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. MetLife Announces Full Year and Fourth Quarter 2024 Results NEW YORK, February 5, 2025 - MetLife, Inc. (NYSE: MET) today announced its full year and fourth quarter 2024 results. Full Year Results Summary •Net income of $4.2 billion, compared to net income of $1.4 billion for the full year 2023. Net income of $5.94 per share

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 7, 2025 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number

As filed with the Securities and Exchange Commission on December 17, 2024

As filed with the Securities and Exchange Commission on December 17, 2024 Registration No.

Filing Fee Table.

Exhibit 107 CALCULATION OF FILING FEE TABLE Form S-8 (Form Type) MetLife, Inc. (Exact name of registrant as specified in its charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Unit Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value $0.01 per

Regulation FD Disclosure, Financial Statements and Exhibits

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 12, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

METLIFE UNVEILS NEW FRONTIER GROWTH STRATEGY AND LONG- TERM FINANCIAL COMMITMENTS AT 2024 INVESTOR DAY • New five-year strategy to accelerate growth across global platform while delivering attractive returns and all-weather performance • Outlines str

METLIFE UNVEILS NEW FRONTIER GROWTH STRATEGY AND LONG- TERM FINANCIAL COMMITMENTS AT 2024 INVESTOR DAY • New five-year strategy to accelerate growth across global platform while delivering attractive returns and all-weather performance • Outlines strong long-term financial commitments including double-digit adjusted earnings per share growth1 and 15-17% adjusted return on equity2 NEW YORK, December 12, 2024 — MetLife, Inc.

Investor Day 2024 2 Introduction INVESTOR DAY 2024 John Hall Agenda for today Michel Khalaf President and Chief Executive Officer New Frontier Strategic Overview Extend Leadership in Group Benefits Ramy Tadros Regional President, US Business and Head

Investor Day 2024 2 Introduction INVESTOR DAY 2024 John Hall Agenda for today Michel Khalaf President and Chief Executive Officer New Frontier Strategic Overview Extend Leadership in Group Benefits Ramy Tadros Regional President, US Business and Head of MetLife Holdings Missy Plohr-Memming Head of National Accounts Michael Roberts Chief Marketing Officer Capitalize on Unique Retirement Platform Ramy Tadros Regional President, U.

MetLife and General Atlantic Announce the Formation of Chariot Re

Exhibit 99.1 MetLife and General Atlantic Announce the Formation of Chariot Re NEW YORK – December 11, 2024 – MetLife, Inc. and General Atlantic today announced the formation of Chariot Reinsurance, Ltd. (“Chariot Re”), a to-be-registered Class E Bermuda-based life and annuity reinsurance company. Chariot Re is expected to launch in the first half of 2025 and will have a future strategic reinsuran

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): December 11, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

METLIFE DECLARES FOURTH QUARTER 2024 PREFERRED STOCK DIVIDENDS

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES FOURTH QUARTER 2024 PREFERRED STOCK DIVIDENDS NEW YORK, November 15, 2024 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.39232690 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 15, 2024 METLIFE, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 15, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

, effective August 1, 2024

Exhibit 10.1 May 16, 2024 Shurawl M. Sibblies [address redacted] Dear Shurawl, I am pleased to offer you the following sign-on payments in connection with the beginning of your employment with MetLife Group, Inc. in the position of Executive Vice President and Chief Human Resources Officer, as approved by MetLife Inc.’s Compensation Committee and Board of Directors. Sign-on Payments Based on the i

MET / MetLife, Inc. / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A 1 d873205dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 99 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLi

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 2 d873205dex991.htm EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 99 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: November 1, 2024

Assets Under Management September 30, 2024 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate. We aim to deliver strong, risk-adjusted

Assets Under Management September 30, 2024 Investors turn to MetLife Investment Management for our client-centric approach and deep, long-established expertise in Fixed Income, Private Capital and Real Estate.

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): October 30, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

Third Quarter Financial Supplement September 30, 2024

Table of Contents Exhibit 99.2 Third Quarter Financial Supplement September 30, 2024 3 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Ad

3Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public di

3Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

METLIFE ANNOUNCES THIRD QUARTER 2024 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES THIRD QUARTER 2024 RESULTS NEW YORK, October 30, 2024 - MetLife, Inc. (NYSE: MET) today announced its third quarter 2024 results. Third Quarter Results Summary •Net income of $1.3 billion, or $1.81 per share, compared to net income of $422 million, or $0.56 per share, in the third quarter of 2023. •Adjuste

Underwriting Agreement, dated as of September 26, 2024, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule I to the Pricing Agreement.

Exhibit 1.1 METLIFE, INC. DEBT SECURITIES UNDERWRITING AGREEMENT September 26, 2024 To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described Ladies and Gentlemen: From time to time, MetLife, Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex

Forty-Seventh Supplemental Indenture, dated as of September 30, 2024, between the Company and the Trustee.

Exhibit 4.3 FORTY-SEVENTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of September 30, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 2 SECTION 1.02 Terms 2 SECTION 1.03 Payment of Principal and Interest 3 SECTION 1.04 Denominations 4 SECTION 1.05 Global Securities 4 SECTION 1.06 Tran

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): September 26, 2024 METLIFE, INC.

Pricing Agreement, dated September 26, 2024, among the Company and Morgan Stanley & Co. LLC, BofA Securities, Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Exhibit 1.2 PRICING AGREEMENT September 26, 2024 Morgan Stanley & Co. LLC BofA Securities, Inc. Wells Fargo Securities, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Morgan Stanley & Co. LLC 1585 Broadway, 29th Floor New York, New York 10036 United States of America c/o BofA Securities, Inc. One Bryant Park New York, New York 10036 United States of America c/o W

Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities

EXHIBIT 107 Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc.

MetLife, Inc. $250,000,000 5.300% Senior Notes due 2034

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 Prospectus Supplement (To Prospectus Dated November 17, 2022) MetLife, Inc. $250,000,000 5.300% Senior Notes due 2034 MetLife, Inc. is offering $250,000,000 aggregate principal amount of its 5.300% Senior Notes due 2034 (the “New Senior Notes”). The New Senior Notes offered hereby will be issued as additional

SUBJECT TO COMPLETION, DATED SEPTEMBER 26, 2024

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 The information contained in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy the Senior Notes in any jurisdiction where the offer or sale is not permitt

MetLife, Inc. $250,000,000 5.300% Senior Notes due 2034 (the “Notes”) Final Term Sheet September 26, 2024

FWP 1 d833586dfwp.htm FWP Filed pursuant to Rule 433 September 26, 2024 Relating to Preliminary Prospectus Supplement dated September 26, 2024 to Prospectus dated November 17, 2022 Registration Statement No. 333-268442 MetLife, Inc. $250,000,000 5.300% Senior Notes due 2034 (the “Notes”) Final Term Sheet September 26, 2024 The information in this final term sheet relates to the offering of the sec

METLIFE DECLARES THIRD QUARTER 2024 PREFERRED STOCK DIVIDENDS

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES THIRD QUARTER 2024 PREFERRED STOCK DIVIDENDS NEW YORK, August 15, 2024 – MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.41713578 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquid

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 15, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number

MET / MetLife, Inc. / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 98 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park Avenue New York, NY 10166-018

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 98 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: August 1, 2024 * Cheryl W. Grisé * Carlos M.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife, I

Assets Under Management June 30, 2024 Investors turn to MetLife Investment Management for our deep and long-established expertise in Fixed Income, Private Capital and Real Estate. Seeking to deliver strong, risk-adjusted returns, we create tailored p

Assets Under Management June 30, 2024 Investors turn to MetLife Investment Management for our deep and long-established expertise in Fixed Income, Private Capital and Real Estate.

METLIFE ANNOUNCES SECOND QUARTER 2024 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES SECOND QUARTER 2024 RESULTS NEW YORK, July 31, 2024 - MetLife, Inc. (NYSE: MET) today announced its second quarter 2024 results. Second Quarter Results Summary •Net income of $912 million, or $1.28 per share, compared to net income of $370 million, or $0.48 per share, in the second quarter of 2023. •Adjust

Second Quarter Financial Supplement June 30, 2024

Table of Contents Exhibit 99.2 Second Quarter Financial Supplement June 30, 2024 2 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Adjust

2Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public di

2Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 31, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 18, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

MetLife Annual Variable Incentive Plan, effective January 1, 2025

Exhibit 10.2 MetLife Annual Variable Incentive Plan Effective January 1, 2025 Article 1. Purpose, Effectiveness, and Duration The MetLife Annual Variable Incentive Plan (“AVIP” or the “Plan”) is an annual cash incentive plan approved by the Company’s Board of Directors. The purpose of AVIP is to provide competitive total compensation opportunities, make a market-aligned portion of total compensati

Pricing Agreement, dated June 3, 2024, among the Company and Citigroup Global Markets Inc., Deutsche Bank Securities, Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Exhibit 1.2 PRICING AGREEMENT June 3, 2024 Citigroup Global Markets Inc. Deutsche Bank Securities Inc. Goldman Sachs & Co. LLC HSBC Securities (USA) Inc. Wells Fargo Securities, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, New York 10013 c/o Deutsche Bank Securities Inc. 1 Columbus Circle New York, Ne

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 3, 2024 METLIFE, INC. (Exact N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 3, 2024 METLIFE, INC.

Forty-Sixth Supplemental Indenture, dated as of June 5, 2024, between the Company and the Trustee.

EX-4.1 Exhibit 4.1 FORTY-SIXTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of June 5, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 2 SECTION 1.02 Establishment 2 SECTION 1.03 Payment of Principal and Interest 3 SECTION 1.04 Denominations 4 SECTION 1.05 Global Securities 4 SECTION 1.

Underwriting Agreement, dated as of June 3, 2024, among the Company and Citigroup Global Markets Inc., Deutsche Bank Securities, Inc., Goldman Sachs & Co. LLC, HSBC Securities (USA) Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule I to the Pricing Agreement.

Exhibit 1.1 METLIFE, INC. DEBT SECURITIES UNDERWRITING AGREEMENT June 3, 2024 To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described Ladies and Gentlemen: From time to time, MetLife, Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I here

MetLife, Inc. $500,000,000 5.300% Senior Notes due 2034

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 Prospectus Supplement (To Prospectus Dated November 17, 2022) MetLife, Inc. $500,000,000 5.300% Senior Notes due 2034 MetLife, Inc. is offering $500,000,000 aggregate principal amount of its 5.300% Senior Notes due 2034 (the “Senior Notes”). Interest on the Senior Notes will accrue at 5.300% per annum from Jun

Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security  Type Security Class Title Fee Calculation or Carry Forward Rule Amount Regi

EXHIBIT 107 Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc.

SUBJECT TO COMPLETION, DATED JUNE 3, 2024

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 The information contained in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy the Senior Notes in any jurisdiction where the offer or sale is not permitt

MetLife, Inc. $500,000,000 5.300% Senior Notes due 2034 Final Term Sheet June 3, 2024

Filed pursuant to Rule 433 June 3, 2024 Relating to Preliminary Prospectus Supplement dated June 3, 2024 to Prospectus dated November 17, 2022 Registration Statement No.

METLIFE DECLARES SECOND QUARTER 2024 PREFERRED STOCK DIVIDENDS

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES SECOND QUARTER 2024 PREFERRED STOCK DIVIDENDS NEW YORK, May 15, 2024 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.43023800 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidat

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number) (

MetLife Exempt Solicitation

MetLife Exempt Solicitation Notice of Exempt Solicitation (Voluntary Submission) Pursuant to Rule 14a-103 Name of the Registrant: MetLife, Inc.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife,

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 2 d787156dex991.htm EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 10 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 97 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: May 2, 2024 * C

MET / MetLife, Inc. / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A 1 d787156dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 97 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park

Exhibit 99.2 Power of Attorney

EX-99.2 3 d787156dex992.htm EX-99.2 Exhibit 99.2 SCHEDULE 13D CUSIP No. 59156R108 Page 10 of 10 Pages POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Monica Curtis, Executive Vice President and Chief Legal Officer, John D. McCallion, Executive Vice President and Chief Financial Officer, and John A. Hall, Executive Vice President and Treasurer,

Assets Under Management March 31, 2024 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate. Seeking to deliver strong, risk-adjusted returns, we create ta

Assets Under Management March 31, 2024 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate.

First Quarter Financial Supplement March 31, 2024

Table of Contents Exhibit 99.2 First Quarter Financial Supplement March 31, 2024 1 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Adjust

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 1, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number) (I

METLIFE ANNOUNCES FIRST QUARTER 2024 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES FIRST QUARTER 2024 RESULTS NEW YORK, May 1, 2024 - MetLife, Inc. (NYSE: MET) today announced its first quarter 2024 results. First Quarter Results Summary •Net income of $800 million, or $1.10 per share, compared to net income of $14 million, or $0.02 per share, in the first quarter of 2023. •Adjusted earn

1Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public di

ex9941q24supplementalsli 1Q24 Supplemental Slides1 John McCallion Chief Financial Officer and Head of MetLife Investment Management Exhibit 99.

MET 2024 PROXY COURTESY COPY

Letter from the Chairman of the Board MetLife, Inc. 200 Park Avenue, New York, NY 10166 April 26, 2024 Dear Fellow Shareholder: We often refer to MetLife’s Next Horizon Strategy as being “all-weather,” and that was truly put to the test over this past year. The Company successfully navigated the uncertainties created by volatility in interest rates, geopolitical unrest and other factors. Through i

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the app

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

METLIFE ANNOUNCES FULL REDEMPTION OF 5.375% SENIOR NOTES DUE 2024

EX-99.1 Exhibit 99.1 METLIFE ANNOUNCES FULL REDEMPTION OF 5.375% SENIOR NOTES DUE 2024 NEW YORK, March 12, 2024 – MetLife, Inc. (NYSE: MET) today announced that it will redeem all of its outstanding 5.375% Senior Notes due December 9, 2024 (the “Notes”), pursuant to the terms of the Notes. The full £350 million outstanding principal amount of the Notes will be redeemed on April 11, 2024 (the “Rede

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 12, 2024 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 12, 2024 METLIFE, INC.

Forty-Fourth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee

Exhibit 4.6 FORTY-FOURTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tr

Fortieth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee.

Exhibit 4.2 FORTIETH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Transf

Forty-Third Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee

Exhibit 4.5 FORTY-THIRD SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tra

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 1, 2024 METLIFE, INC.

Forty-First Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee.

Exhibit 4.3 FORTY-FIRST SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tra

Pricing Agreement, dated March 1, 2024, among the Company and Mizuho Securities USA LLC, Morgan Stanley & Co. International plc, SMBC Nikko Securities America, Inc., and Merrill Lynch International, as representatives of the several underwriters named therein.

Exhibit 1.2 PRICING AGREEMENT March 1, 2024 Mizuho Securities USA LLC Morgan Stanley & Co. International plc SMBC Nikko Securities America, Inc. Merrill Lynch International As Representatives of the several Underwriters named in Schedule I hereto c/o Mizuho Securities USA LLC 1271 Avenue of the Americas New York, NY 10020 United States of America c/o Morgan Stanley & Co. International plc 25 Cabot

Forty-Second Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee.

Exhibit 4.4 FORTY-SECOND SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tr

Underwriting Agreement, dated as of March 1, 2024, among the Company and Mizuho Securities USA LLC, Morgan Stanley & Co. International plc, SMBC Nikko Securities America, Inc., and Merrill Lynch International, as representatives of the several underwriters named in Schedule I to the Pricing Agreement.

Exhibit 1.1 METLIFE, INC. DEBT SECURITIES UNDERWRITING AGREEMENT March 1, 2024 To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described Ladies and Gentlemen: From time to time, MetLife, Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I her

Thirty-Ninth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee.

Exhibit 4.1 THIRTY-NINTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tr

Forty-Fifth Supplemental Indenture, dated as of March 7, 2024, between the Company and the Trustee

Exhibit 4.7 FORTY-FIFTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of March 7, 2024 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 3 SECTION 1.03 Payment of Principal and Interest 4 SECTION 1.04 Denominations 5 SECTION 1.05 Global Securities 5 SECTION 1.06 Tra

METLIFE CONFIRMS FIRST QUARTER 2024 SERIES A PREFERRED STOCK DIVIDEND

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE CONFIRMS FIRST QUARTER 2024 SERIES A PREFERRED STOCK DIVIDEND NEW YORK, March 5, 2024 — MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2024 dividend of $0.42000544 per share on the company’s floating rate non-cumulative preferred stock, Serie

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 5, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security  Type  Security  Class  Title  Fee  Calculation  or Carry  Forward  Rule  Am

EXHIBIT 107 Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc.

¥112,300,000,000 MetLife, Inc. ¥7,100,000,000  1.009% Senior Notes due 2029 ¥23,100,000,000 1.415% Senior Notes due 2031 ¥16,700,000,000 1.670% Senior Notes due 2034 ¥11,200,000,000 1.953% Senior Notes due 2039 ¥15,500,000,000 2.195% Senior Notes due

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 Prospectus Supplement (To Prospectus Dated November 17, 2022) ¥112,300,000,000 MetLife, Inc. ¥7,100,000,000  1.009% Senior Notes due 2029 ¥23,100,000,000 1.415% Senior Notes due 2031 ¥16,700,000,000 1.670% Senior Notes due 2034 ¥11,200,000,000 1.953% Senior Notes due 2039 ¥15,500,000,000 2.195% Senior Notes du

MetLife, Inc. ¥7,100,000,000 1.009% Senior Notes due 2029 ¥23,100,000,000 1.415% Senior Notes due 2031 ¥16,700,000,000 1.670% Senior Notes due 2034 ¥11,200,000,000 1.953% Senior Notes due 2039 ¥15,500,000,000 2.195% Senior Notes due 2044 ¥23,500,000,

Filed pursuant to Rule 433 March 1, 2024 Relating to Preliminary Prospectus Supplement dated February 26, 2024 to Prospectus dated November 17, 2022 Registration Statement No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2024 METLIFE, INC. (

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 27, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

SUBJECT TO COMPLETION, DATED FEBRUARY 26, 2024

Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No. 333-268442 The information contained in this preliminary prospectus supplement is not complete and may be changed. Neither this preliminary prospectus supplement nor the accompanying prospectus is an offer to sell nor does it seek an offer to buy the Senior Notes in any jurisdiction where the offer or sale is not permitt

Description of Securities.

Exhibit 4.18 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of MetLife, Inc.’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is a summary and does not purport to be complete. It is qualified in its entirety by reference to our amended an

Amendment Number 8 to the MetLife Auxiliary Match Plan (Amended and Restated Effective January 1, 2008), dated November 20, 2023 (effective December 1, 2023).*

Exhibit 10.24.9 AMENDMENT NUMBER 8 TO THE METLIFE AUXILIARY MATCH PLAN (Amended and Restated, Effective January 1, 2008) The MetLife Auxiliary Match Plan (the “Plan”) is hereby amended, effective as of December 1, 2023, as follows: Section 4.15 shall be added with the following language: 4.15 Dodd-Frank Recoupment/Clawback: Notwithstanding anything contained herein to the contrary, a Participant’s

MetLife Plan for Transition Assistance for Grades 14 and Above, dated November 22, 2023 (as amended and restated, effective November 1, 2023).*

EXHIBIT 10.27.1 METLIFE PLAN FOR TRANSITION ASSISTANCE FOR GRADES 14 AND ABOVE Amended and Restated Effective November 1, 2023 TABLE OF CONTENTS Article 1 – The Plan: Effective Date: Plan Year: Definitions 1 Article 2 – Funding 8 Article 3 – Fiduciaries 9 Article 4 – Plan Benefits 10 Article 5 – Operation of the Plan 11 Article 6 – Amendment and Termination of Plan 13 Article 7 – Change of control

MetLife Policy for the Recoupment of Erroneously Awarded Compensation under the Dodd-Frank Wall Street Reform and Consumer Protection Act (effective December 1, 2023).*

Exhibit 97.1 MetLife Policy for the Recoupment of Erroneously Awarded Compensation under the Dodd-Frank Wall Street Reform and Consumer Protection Act (the “Policy”) (Effective December 1, 2023, the “Effective Date”) 1.Purpose. The purpose of this Policy is to describe the circumstances in which covered Executives will be required to repay or return Erroneously Awarded Compensation to MetLife. Thi

MetLife Performance-Based Compensation Recoupment Policy (effective as amended and restated December 1, 2023).*

Exhibit 10.10 MetLife Performance-Based Compensation Recoupment Policy (Effective as amended and restated December 1, 2023) 1. Purpose. The purpose of this Policy is to describe circumstances (in addition to those covered by the Dodd-Frank Recoupment Policy) in which MetLife may seek Recoupment of performance-based compensation. 2. Definitions. For purposes of this Policy, capitalized terms shall

Subsidiaries of the Registrant.

Exhibit 21.1 METLIFE, INC. As of 12/31/23 Wholly-Owned Active Subsidiaries1 1. 150 NORTH RIVERSIDE PE MEMBER, LLC (DE) 2. 23RD STREET INVESTMENTS, INC. (DE) 3. 500 GRANT STREET ASSOCIATES LIMITED PARTNERSHIP (CT) 4. 500 GRANT STREET GP LLC (DE) 5. 1201 TAB MANAGER, LLC (DE) 6. 1350 EYE STREET MANAGER LLC (DE 7. 1350 EYE STREET OWNER LLC (DE) 8. 6104 HOLLYWOOD, LLC (DE) 9. 10700 WILSHIRE, LLC (DE)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-15787 MetLife, Inc.

Amendment Number 12 to the MetLife Auxiliary Retirement Plan (as amended and restated, effective January 1, 2008), dated November 20, 2023 (effective December 1, 2023).*

Exhibit 10.21.16 AMENDMENT NUMBER 12 TO THE METLIFE AUXILIARY RETIREMENT PLAN (As amended and restated effective January 1, 2008) The MetLife Auxiliary Retirement Plan (the “Plan”) is hereby amended, effective as of December 1, 2023, as follows: Section 4.9 shall be added with the following language: 4.9 Dodd-Frank Recoupment/Clawback: Notwithstanding anything contained herein to the contrary, a P

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 2 d751988dex991.htm EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 96 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: February 15, 202

MET / MetLife, Inc. / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 96 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park Avenue New York, NY 10166-018

METLIFE ANNOUNCES FIRST QUARTER 2024 PREFERRED STOCK DIVIDEND ACTIONS Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE ANNOUNCES FIRST QUARTER 2024 PREFERRED STOCK DIVIDEND ACTIONS Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation NEW YORK, February 15, 2024 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock di

MET / MetLife, Inc. / DODGE & COX - SC 13G/A Passive Investment

SC 13G/A 1 d478782dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 4)* MetLife, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 59156R108 (CUSIP Number) December 31, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

MET / MetLife, Inc. / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv0091-metlifeinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 8)* Name of issuer: MetLife Inc Title of Class of Securities: Common Stock CUSIP Number: 59156R108 Date of Event Which Requires Filing of this Statement: December 29, 2023 Check the appropriate box to designate the rule pur

4Q23 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results i

ex9944q23supplementalsli 4Q23 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer Exhibit 99.

METLIFE ANNOUNCES FULL YEAR AND FOURTH QUARTER 2023 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES FULL YEAR AND FOURTH QUARTER 2023 RESULTS NEW YORK, January 31, 2024 - MetLife, Inc. (NYSE: MET) today announced its full year and fourth quarter 2023 results. Full Year Results Summary* •Net income of $1.4 billion, compared to net income of $5.1 billion for the full year 2022. Net income of $1.81 per shar

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 31, 2024 METLIFE, INC. (E

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): January 31, 2024 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

Fourth Quarter Financial Supplement December 31, 2023

Table of Contents Exhibit 99.2 Fourth Quarter Financial Supplement December 31, 2023 4 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 Group Benefits Statements of Ad

Assets Under Management December 31, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate. Seeking to deliver strong, risk-adjusted returns, we create

ex993q42023totalaum Assets Under Management December 31, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate.

Regulation FD Disclosure, Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 16, 2023 METLIFE, INC.

METLIFE COMPLETES RISK TRANSFER TRANSACTION WITH GLOBAL ATLANTIC FINANCIAL GROUP

EX-99.1 Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE COMPLETES RISK TRANSFER TRANSACTION WITH GLOBAL ATLANTIC FINANCIAL GROUP NEW YORK, November 16, 2023 – MetLife, Inc. (NYSE: MET) today announced it has completed its risk transfer transaction with Global Atlantic Financial Group, a retirement and life insurance company. The transaction accelerates the run-of

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 15, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numb

METLIFE DECLARES FOURTH QUARTER 2023 PREFERRED STOCK DIVIDENDS

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES FOURTH QUARTER 2023 PREFERRED STOCK DIVIDENDS NEW YORK, November 15, 2023 – MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: •Quarterly dividend of $0.42157266 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liq

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED SEPTEMBER 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLi

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 2 d559074dex991.htm EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 94 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: November 2, 2023

MET / Metlife Inc / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A 1 d559074dsc13da.htm SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 95 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park

Assets Under Management September 30, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate. Seeking to deliver strong, risk-adjusted returns, we creat

Assets Under Management September 30, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate.

METLIFE ANNOUNCES THIRD QUARTER 2023 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES THIRD QUARTER 2023 RESULTS NEW YORK, November 1, 2023 - MetLife, Inc. (NYSE: MET) today announced its third quarter 2023 results. Third Quarter Results Summary* •Net income of $422 million, or $0.56 per share, compared to net income of $1.1 billion, or $1.37 per share, in the third quarter of 2022. •Adjust

Third Quarter Financial Supplement September 30, 2023

EX-99.2 3 ex992qfsq323doc.htm EX-99.2 Table of Contents Exhibit 99.2 Third Quarter Financial Supplement September 30, 2023 3 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOL

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): November 1, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

3Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this prese

3Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this presentation reflect LDTI accounting, pursuant to Financial Accounting Standards Board Accounting Standards Update No. 2018-12, which became effective on J

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K/A Amendment No.

Amended and Restated By-Laws of MetLife, Inc., effective as of October 3, 2023, redlined for amendments effective as of October 3, 2023.

Exhibit 3.1 METLIFE, INC. AMENDED AND RESTATED BY-LAWS Effective September 25October 3, 201823 TABLE OF CONTENTS ARTICLE I STOCKHOLDERS 5 Section 1.01   Annual Meetings 5 Section 1.02   Special Meetings 5 Section 1.03   Notice of Meetings; Waiver 78 Section 1.04   Quorum and Required Vote 79 Section 1.05   Voting Rights 79 Section 1.06   Voting by Ballot 79 Section 1.07   Adjournment 79 Section 1.

Amended and Restated By-Laws of MetLife, Inc., effective October 3, 2023.

Exhibit 3.2 METLIFE, INC. AMENDED AND RESTATED BY-LAWS Effective October 3, 2023 TABLE OF CONTENTS ARTICLE I STOCKHOLDERS 5 Section 1.01  Annual Meetings 5 Section 1.02  Special Meetings 5 Section 1.03  Notice of Meetings; Waiver 8 Section 1.04  Quorum and Required Vote 8 Section 1.05  Voting Rights 9 Section 1.06  Voting by Ballot 9 Section 1.07  Adjournment 9 Section 1.08  Proxies 9 Section 1.09

Current Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 3, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 15, 2023 METLIFE, INC.

METLIFE DECLARES THIRD QUARTER 2023 PREFERRED STOCK DIVIDENDS

EX-99.1 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES THIRD QUARTER 2023 PREFERRED STOCK DIVIDENDS NEW YORK, Aug. 15, 2023 – MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: • Quarterly dividend of $0.41860000 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a

MET / Metlife Inc / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 94 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Monica M. Curtis Executive Vice President and Chief Legal Officer MetLife, Inc. 200 Park Avenue New York, NY 10166-018

Exhibit 99.1 Joint Filing Agreement under Rule 13d-1(k)(1)

EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 94 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: August 3, 2023 * Cheryl W. Grisé * Carlos M.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife, I

2Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this prese

ex9942q23supplementalsli 2Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.

METLIFE ANNOUNCES SECOND QUARTER 2023 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES SECOND QUARTER 2023 RESULTS NEW YORK, August 2, 2023 - MetLife, Inc. (NYSE: MET) today announced its second quarter 2023 results. Second Quarter Results Summary* •Net income of $370 million, or $0.48 per share, compared to net income of $881 million, or $1.08 per share, in the second quarter of 2022. •Adju

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): August 2, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Assets Under Management June 30, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate. Seeking to deliver strong, risk-adjusted returns, we create tai

ex993q22023totalaum Assets Under Management June 30, 2023 Investors turn to MetLife Investment Management for our deep and long-established expertise in Public Fixed Income, Private Capital and Real Estate.

Second Quarter Financial Supplement June 30, 2023

Table of Contents Exhibit 99.2 Second Quarter Financial Supplement June 30, 2023 2 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 U.S. Statements of Adjusted Earning

Thirty-Eighth Supplemental Indenture, dated as of July 12, 2023, between the Company and the Trustee.

EX-4.1 Exhibit 4.1 THIRTY-EIGHTH SUPPLEMENTAL INDENTURE between METLIFE, INC., as Issuer, and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A., as Trustee Dated as of July 12, 2023 TABLE OF CONTENTS Page ARTICLE I SENIOR NOTES SECTION 1.01 Definitions 1 SECTION 1.02 Establishment 2 SECTION 1.03 Payment of Principal and Interest 3 SECTION 1.04 Denominations 4 SECTION 1.05 Global Securities 4 SECTION

Underwriting Agreement, dated as of July 10, 2023, among the Company and Barclays Capital Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named in Schedule I to the Pricing Agreement.

Exhibit 1.1 METLIFE, INC. DEBT SECURITIES UNDERWRITING AGREEMENT July 10, 2023 To the Representatives of the several Underwriters named in the respective Pricing Agreements hereinafter described Ladies and Gentlemen: From time to time, MetLife, Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I her

Pricing Agreement, dated July 10, 2023, among the Company and Barclays Capital Inc., Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, Morgan Stanley & Co. LLC and Wells Fargo Securities, LLC, as representatives of the several underwriters named therein.

Exhibit 1.2 PRICING AGREEMENT July 10, 2023 Barclays Capital Inc. Citigroup Global Markets Inc. Goldman Sachs & Co. LLC Morgan Stanley & Co. LLC Wells Fargo Securities, LLC As Representatives of the several Underwriters named in Schedule I hereto c/o Barclays Capital Inc. 745 7th Avenue New York, NY 10019 c/o Citigroup Global Markets Inc. 388 Greenwich Street New York, NY 10013 c/o Goldman Sachs &

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 10, 2023 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): July 10, 2023 METLIFE, INC.

MetLife, Inc. $1,000,000,000 5.375% Senior Notes due 2033

424B2 Table of Contents Filed Pursuant to Rule 424(b)(2) Registration Statement No.

Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation or Carry Forward Rule Amount Regis

EX-FILING FEES EXHIBIT 107 Calculation of Filing Fee Table FORM 424(b)(2) (Form Type) MetLife, Inc.

SUBJECT TO COMPLETION, DATED JULY 10, 2023

424B2 Table of Contents The information contained in this preliminary prospectus supplement is not complete and may be changed.

MetLife, Inc. $1,000,000,000 5.375% Senior Notes due 2033 Final Term Sheet July 10, 2023

FWP Filed pursuant to Rule 433 July 10, 2023 Relating to Preliminary Prospectus Supplement dated July 10, 2023 to Prospectus dated November 17, 2022 Registration Statement No.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 20, 2023 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 20, 2023 METLIFE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2023 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): June 16, 2023 METLIFE, INC.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 METLIFE, INC. (Exact N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 25, 2023 METLIFE, INC.

Cautionary Statement on Forward-Looking Statements The forward-looking statements in this presentation, using words such as “anticipate,” “are confident,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “grow,” “guidance,” “if,” “inte

EX-99.2 Exhibit 99.2 MetLife Announces ~$19.2 Billion Risk Transfer Transaction and Increase to Share Repurchase Authorization May 25, 2023 Cautionary Statement on Forward-Looking Statements The forward-looking statements in this presentation, using words such as “anticipate,” “are confident,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “grow,” “guidance,” “if,” “intend,” “like

METLIFE ANNOUNCES $19.2 BILLION RISK TRANSFER TRANSACTION; FURTHER INCREASES SHARE REPURCHASE AUTHORIZATION TO $4 BILLION

EX-99.1 Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES $19.2 BILLION RISK TRANSFER TRANSACTION; FURTHER INCREASES SHARE REPURCHASE AUTHORIZATION TO $4 BILLION • Agreement with Global Atlantic to reinsure approximately $19.2 billion of U.S. retail life insurance and fixed annuity statutory reserves • MetLife Board of Directors approves a further increas

METLIFE DECLARES SECOND QUARTER 2023 PREFERRED STOCK DIVIDENDS

EX-99.1 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE DECLARES SECOND QUARTER 2023 PREFERRED STOCK DIVIDENDS NEW YORK, May 15, 2023 — MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock dividends: • Quarterly dividend of $0.37479075 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2023 METLIFE, INC. (Exact N

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 15, 2023 METLIFE, INC.

Amended and Restated Credit Agreement, dated as of May 8, 2023, among MetLife, Inc. and MetLife Funding, Inc., as borrowers, and the other parties signatory thereto.

EX-10.1 Exhibit 10.1 Execution Version Deal CUSIP Number: 59157FBF9 Revolver CUSIP Number: 59157FBG7 AMENDED AND RESTATED CREDIT AGREEMENT dated as of May 8, 2023 among METLIFE, INC. and METLIFE FUNDING, INC., as Borrowers, BANK OF AMERICA, N.A., as Administrative Agent and Several L/C Agent, and The Other Lenders Party Hereto JPMORGAN CHASE BANK, N.A. and WELLS FARGO BANK, NATIONAL ASSOCIATION, a

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2023 METLIFE, INC. (Exact Na

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 8, 2023 METLIFE, INC.

MET / Metlife Inc / BOARD OF DIRECTORS OF METLIFE INC - SC 13D/A Activist Investment

SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 93 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Stephen W. Gauster Executive Vice President and General Counsel MetLife, Inc. 200 Park Avenue New York, NY 10166-0188

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission file number: 001-15787 MetLife,

SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT

EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 93 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: May 4, 2023 * Cheryl W. Grisé * Carlos M. Gu

Exhibit 99.2 Power of Attorney

EX-99.2 Exhibit 99.2 POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Stephen Gauster, Executive Vice President and General Counsel, John McCallion, Executive Vice President and Chief Financial Officer, and John Hall, Executive Vice President and Treasurer, or any of them, and their respective successors from time to time in the offices of Gene

First Quarter Financial Supplement March 31, 2023

Table of Contents Exhibit 99.2 First Quarter Financial Supplement March 31, 2023 1 Table of Contents METLIFE TABLE OF CONTENTS GAAP CONSOLIDATED STATEMENTS OF OPERATIONS 2 CORPORATE OVERVIEW 3 KEY ADJUSTED EARNINGS STATEMENT LINE ITEMS 5 EXPENSE DETAIL AND RATIOS 7 GAAP CONSOLIDATED BALANCE SHEETS 8 SUMMARY OF ADJUSTED EARNINGS AVAILABLE TO COMMON SHAREHOLDERS 9 U.S. Statements of Adjusted Earning

1Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.4 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. Financial results in this prese

ex9941q23supplementalsli 1Q23 Supplemental Slides1 John McCallion Chief Financial Officer Exhibit 99.

METLIFE ANNOUNCES FIRST QUARTER 2023 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES FIRST QUARTER 2023 RESULTS NEW YORK, May 3, 2023 - MetLife, Inc. (NYSE: MET) today announced its first quarter 2023 results. First Quarter Results Summary* •Net income of $14 million, or $0.02 per share, compared to net income of $1.6 billion, or $1.89 per share, in the first quarter of 2022. •Adjusted ear

Total AUM Fact Sheet as of March 31, 2023

q12023totalaum05032023wi

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 3, 2023 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): May 3, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number) (I

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the app

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 14A PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES EXCHANGE ACT OF 1934 Filed by the Registrant þ Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) þ Definitive Proxy State

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 17, 2023 METLIFE, INC. (Exa

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): April 17, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Number)

Historical Results* Financial Supplement Presented in a Revised Format for the Quarters Ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022 and the Year Ended December 31, 2022 Presented to Conform with the Presentation Adop

Table of Contents Exhibit 99.1 Historical Results* Financial Supplement Presented in a Revised Format for the Quarters Ended March 31, 2022, June 30, 2022, September 30, 2022 and December 31, 2022 and the Year Ended December 31, 2022 Presented to Conform with the Presentation Adopted for the First Quarter 2023 Financial Supplement *On January 1, 2023, the Company adopted ASU 2018-12, Financial Ser

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 6, 2023 METLIFE, INC. (Exact

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): March 6, 2023 METLIFE, INC.

METLIFE CONFIRMS FIRST QUARTER 2023 SERIES A PREFERRED STOCK DIVIDEND

EX-99.1 Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE CONFIRMS FIRST QUARTER 2023 SERIES A PREFERRED STOCK DIVIDEND NEW YORK, March 6, 2023 – MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2023 dividend of $0.36056250 per share on the company’s floating rate non-cumulative preferred stoc

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 28, 2023 METLIFE, INC. (Ex

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 28, 2023 METLIFE, INC.

Subsidiaries of the Registrant.

Exhibit 21.1 METLIFE, INC. As of 12/31/22 Wholly-Owned Active Subsidiaries1 1. 150 NORTH RIVERSIDE PE MEMBER, LLC (DE) 2. 23RD STREET INVESTMENTS, INC. (DE) 3. 500 GRANT STREET ASSOCIATES LIMITED PARTNERSHIP (CT) 4. 500 GRANT STREET GP LLC (DE) 5. 1201 TAB MANAGER, LLC (DE) 6. 1350 EYE STREET MANAGER LLC (DE 7. 1350 EYE STREET OWNER LLC (DE) 8. 6104 HOLLYWOOD, LLC (DE) 9. 10700 WILSHIRE, LLC (DE)

Description of Securities.

Exhibit 4.18 DESCRIPTION OF REGISTRANT’S SECURITIES REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934 The following description of MetLife, Inc.’s securities registered pursuant to Section 12 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is a summary and does not purport to be complete. It is qualified in its entirety by reference to our amended an

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☑ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-15787 MetLife, Inc.

Form of Performance Share Agreement under the 2015 SIC Plan, effective February 28, 2023.*

Exhibit 10.18.6 PERFORMANCE SHARE AGREEMENT MetLife, Inc. confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Performance Shares (your “Performance Shares”). Your Performance Shares are subject to the terms and conditions of the MetLife, Inc. 2015 Stock and Incentive Compensation Plan (the “Plan”) and this Performance Share Agreement (this “Agreement”), which includ

SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT

EX-99.1 Exhibit 99.1 SCHEDULE 13D CUSIP No. 59156R108 Page 8 of 9 Pages JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1)(iii) promulgated under the Securities Exchange Act of 1934, as amended, each of the undersigned agrees that the Statement on Amendment No. 92 to Schedule 13D, to which this exhibit is attached, is filed on his or her behalf. Dated: February 23, 2023 * Cheryl W. Grisé * Carlos

Form of Performance Unit Agreement under the 2015 SIC Plan, effective February 28, 2023.*

Exhibit 10.19.6 PERFORMANCE UNIT AGREEMENT [Global Affiliate] (the “Global Affiliate”) confirms that, on [grant date] (the “Grant Date”), it granted you, [name], [number] Performance Units (your “Performance Units”), and approves and ratifies such grant. Your Performance Units are subject to the terms and conditions of the MetLife, Inc. 2015 Stock and Incentive Compensation Plan (the “Plan”) and t

MET / Metlife Inc / BOARD OF DIRECTORS OF METLIFE INC - AMENDMENT NO. 92 TO SCHEDULE 13D Activist Investment

Amendment No. 92 to Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 AMENDMENT NO. 92 TO SCHEDULE 13D Under the Securities Exchange Act of 1934 MetLife, Inc. (Name of Issuer) Common Stock, par value $.01 per share (Title of Class of Securities) 59156R108 (CUSIP Number) Stephen W. Gauster Executive Vice President and General Counsel MetLife, Inc. 200 Park Avenue

Financial Statements and Exhibits, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 15, 2023 METLIFE, INC.

METLIFE ANNOUNCES FIRST QUARTER 2023 PREFERRED STOCK DIVIDEND ACTIONS Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation

Exhibit 99.1 For Immediate Release | Global Communications | MetLife, Inc. METLIFE ANNOUNCES FIRST QUARTER 2023 PREFERRED STOCK DIVIDEND ACTIONS Declares Series D, E, F and G Preferred Stock Dividends Declares Series A Preferred Stock Dividend, Subject to Final Confirmation NEW YORK, February 15, 2023 – MetLife, Inc. (NYSE: MET) today announced that it has declared the following preferred stock di

MET / Metlife Inc / DODGE & COX - SC 13G/A Passive Investment

SC 13G/A 1 d435635dsc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (AMENDMENT NO. 3)* MetLife, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 59156R108 (CUSIP Number) December 31, 2022 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate th

MET / Metlife Inc / VANGUARD GROUP INC - SCHEDULE 13G/A Passive Investment

SC 13G/A 1 tv01413-metlifeinc.htm SCHEDULE 13G/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 7)* Name of issuer: MetLife Inc. Title of Class of Securities: Common Stock CUSIP Number: 59156R108 Date of Event Which Requires Filing of this Statement: December 30, 2022 Check the appropriate box to designate the rule p

Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 7, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

Total AUM Fact Sheet as of December 31, 2022

METLIFE ANNOUNCES FULL YEAR AND FOURTH QUARTER 2022 RESULTS

Exhibit 99.1 For Immediate Release İ Global Communications İ MetLife, Inc. METLIFE ANNOUNCES FULL YEAR AND FOURTH QUARTER 2022 RESULTS NEW YORK, February 1, 2023 - MetLife, Inc. (NYSE: MET) today announced its full year and fourth quarter 2022 results. Full Year Results Summary •Net income of $2.4 billion, compared to net income of $6.4 billion for the full year 2021. Net income of $2.91 per share

Regulation FD Disclosure, Financial Statements and Exhibits, Results of Operations and Financial Condition, Other Events

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of report (Date of earliest event reported): February 1, 2023 METLIFE, INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation) 1-15787 13-4075851 (Commission File Numbe

4Q22 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer Exhibit 99.3 1 These slides highlight information in MetLife, Inc.'s earnings release, quarterly financial supplement and other prior public disclosures. 2 Table of contents

4Q22 Supplemental Slides and Outlook1 John McCallion Chief Financial Officer Exhibit 99.